Guselkumab for the treatment of psoriasis

M Megna, A Balato, A Raimondo… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Psoriasis is a chronic immune mediated disease in which the interplay of T
cells and keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 …
被引用次数：49 相关文章

Guselkumab for the treatment of psoriasis

M Megna, A Balato, A Raimondo, N Balato - EXPERT OPINION ON …, 2018 - iris.unina.it
Psoriasis is a chronic immune mediated disease in which the interplay of T cells and
keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is …

Guselkumab for the treatment of psoriasis

M Megna, A Balato, A Raimondo, N Balato - EXPERT OPINION ON …, 2018 - iris.unisa.it
Introduction: Psoriasis is a chronic immune mediated disease in which the interplay of T
cells and keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 …

Guselkumab for the treatment of psoriasis

M Megna, A Balato, A Raimondo… - EXPERT OPINION ON …, 2018 - iris.unicampania.it
Psoriasis is a chronic immune mediated disease in which the interplay of T cells and
keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is …

Guselkumab for the treatment of psoriasis

M Megna, A Balato, A Raimondo… - Expert opinion on …, 2018 - pubmed.ncbi.nlm.nih.gov
Psoriasis is a chronic immune mediated disease in which the interplay of T cells and
keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is …

Guselkumab for the treatment of psoriasis.

M Megna, A Balato, A Raimondo… - Expert Opinion on …, 2018 - europepmc.org
Psoriasis is a chronic immune mediated disease in which the interplay of T cells and
keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is …